NPM1 and acute myeloid leukemia: The MI-3454 inhibitor was very effective in inhibiting cell proliferation and differentiation of NPM1-mutated AML cells, independently from the coexistence of other mutations in patients’ samples, and in reducing blast infiltration of organs and expression of MEIS1 and FLT3 in PDX NPM1-mutated mouse models [95].